Respiratory microbiome: evidence from basic and clinical studies

Objective: In recent years, culture-independent methods led to provide a strong background to further microbiota studies, especially in lower respiratory tract investigation. Scientific research has focused more on studying and characterizing relationships between lung microbiota and various disease...

Full description

Bibliographic Details
Main Authors: V. Ankudavicius, J. Skieceviciene, D. Nikitina, R. Lukosevicius, S. Miliauskas, M. Zemaitis
Format: Article
Language:English
Published: Verduci Editore 2023-10-01
Series:Microbiota in Health and Disease
Subjects:
Online Access:https://www.microbiotajournal.com/wp-content/uploads/sites/7/2023/10/e873.pdf
_version_ 1797368594252693504
author V. Ankudavicius
J. Skieceviciene
D. Nikitina
R. Lukosevicius
S. Miliauskas
M. Zemaitis
author_facet V. Ankudavicius
J. Skieceviciene
D. Nikitina
R. Lukosevicius
S. Miliauskas
M. Zemaitis
author_sort V. Ankudavicius
collection DOAJ
description Objective: In recent years, culture-independent methods led to provide a strong background to further microbiota studies, especially in lower respiratory tract investigation. Scientific research has focused more on studying and characterizing relationships between lung microbiota and various diseases, such as lung cancer, chronic obstructive pulmonary disease (COPD), asthma, sarcoidosis, acute respiratory infection, etc. Materials and Methods: The electronic search was performed on the PubMed database using the combination of the text words “respiratory microbiota” and “lung microbiome”. Only research studies in humans published between March 2022 and March 2023 were eligible for inclusion. Results: The scientific search retrieved 124 results, from which 106 articles were excluded if they duplicate or did not fit the inclusion criteria. A total of 18 studies were included for review. Conclusions: These studies have shown that changes in lower respiratory microbiota composition are a variable characteristic of all the aforementioned conditions; the relationship between circulating biomarkers, clinical data, and dysbiosis also was found in several studies. However, some studies had limitations, and future investigations are needed to better understand lung microbiota involvement in the pathogenesis of respiratory diseases.
first_indexed 2024-03-08T17:34:53Z
format Article
id doaj.art-74458870d7564c77b31d99ad6bf52ecf
institution Directory Open Access Journal
issn 2704-8845
language English
last_indexed 2024-03-08T17:34:53Z
publishDate 2023-10-01
publisher Verduci Editore
record_format Article
series Microbiota in Health and Disease
spelling doaj.art-74458870d7564c77b31d99ad6bf52ecf2024-01-02T13:19:19ZengVerduci EditoreMicrobiota in Health and Disease2704-88452023-10-01510.26355/mhd_202310_873873Respiratory microbiome: evidence from basic and clinical studiesV. Ankudavicius0J. Skieceviciene1D. Nikitina2R. Lukosevicius3S. Miliauskas4M. Zemaitis5Department of Pulmonology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaInstitute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, LithuaniaInstitute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, LithuaniaInstitute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Pulmonology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaDepartment of Pulmonology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, LithuaniaObjective: In recent years, culture-independent methods led to provide a strong background to further microbiota studies, especially in lower respiratory tract investigation. Scientific research has focused more on studying and characterizing relationships between lung microbiota and various diseases, such as lung cancer, chronic obstructive pulmonary disease (COPD), asthma, sarcoidosis, acute respiratory infection, etc. Materials and Methods: The electronic search was performed on the PubMed database using the combination of the text words “respiratory microbiota” and “lung microbiome”. Only research studies in humans published between March 2022 and March 2023 were eligible for inclusion. Results: The scientific search retrieved 124 results, from which 106 articles were excluded if they duplicate or did not fit the inclusion criteria. A total of 18 studies were included for review. Conclusions: These studies have shown that changes in lower respiratory microbiota composition are a variable characteristic of all the aforementioned conditions; the relationship between circulating biomarkers, clinical data, and dysbiosis also was found in several studies. However, some studies had limitations, and future investigations are needed to better understand lung microbiota involvement in the pathogenesis of respiratory diseases.https://www.microbiotajournal.com/wp-content/uploads/sites/7/2023/10/e873.pdflung microbiotamicrobiomelung diseases.
spellingShingle V. Ankudavicius
J. Skieceviciene
D. Nikitina
R. Lukosevicius
S. Miliauskas
M. Zemaitis
Respiratory microbiome: evidence from basic and clinical studies
Microbiota in Health and Disease
lung microbiota
microbiome
lung diseases.
title Respiratory microbiome: evidence from basic and clinical studies
title_full Respiratory microbiome: evidence from basic and clinical studies
title_fullStr Respiratory microbiome: evidence from basic and clinical studies
title_full_unstemmed Respiratory microbiome: evidence from basic and clinical studies
title_short Respiratory microbiome: evidence from basic and clinical studies
title_sort respiratory microbiome evidence from basic and clinical studies
topic lung microbiota
microbiome
lung diseases.
url https://www.microbiotajournal.com/wp-content/uploads/sites/7/2023/10/e873.pdf
work_keys_str_mv AT vankudavicius respiratorymicrobiomeevidencefrombasicandclinicalstudies
AT jskieceviciene respiratorymicrobiomeevidencefrombasicandclinicalstudies
AT dnikitina respiratorymicrobiomeevidencefrombasicandclinicalstudies
AT rlukosevicius respiratorymicrobiomeevidencefrombasicandclinicalstudies
AT smiliauskas respiratorymicrobiomeevidencefrombasicandclinicalstudies
AT mzemaitis respiratorymicrobiomeevidencefrombasicandclinicalstudies